Heart attack patients may ditch aspirin: new trial tests safer drug combo
NCT ID NCT07257198
First seen Dec 08, 2025 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests whether using only the blood thinner ticagrelor (instead of the usual aspirin plus ticagrelor) can lower bleeding risks in people who had a heart attack but did not get stents or bypass surgery. About 2,570 adults will be followed for 12 months to see if the single-drug approach is safer without raising the chance of another heart attack, stroke, or death. The goal is to find a treatment that controls the disease with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montreal Heart Institute
RECRUITINGMontreal, Quebec, H1Y2P3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.